HealthWarehouse Q3 sales fall amid GLP-1 market shifts

Reuters
2025/11/13
HealthWarehouse Q3 sales fall amid GLP-1 market shifts

Overview

  • HealthWarehouse.com Q3 sales decline 7% due to slowing DTC sales and GLP-1 market shifts

  • Company reports Q3 net loss of $72,000 but positive cash flow achieved

  • Year-to-date sales increase 97% over prior year, reflecting strong growth

Outlook

  • HealthWarehouse.com optimistic about new product launches diversifying its catalog

  • Company focusing on direct-to-patient market opportunities

  • HealthWarehouse.com investing in technology for efficiency and scalability

Result Drivers

  • GLP-1 MARKET SHIFT - Decline in sales driven by reduced compounded GLP-1 prescription sales

  • DTC SALES DECLINE - Direct-to-consumer prescription sales fell, impacting overall revenue

  • CASH FLOW POSITIVE - Despite sales decline, company achieved positive cash flow and increased cash reserves

Key Details

Metric

Beat/Miss

Actual

Consensus Estimate

Q3 Sales

$8.4 mln

Press Release: ID:nBwbJfykfa

For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact RefinitivNewsSupport@thomsonreuters.com.

(This story was created using Reuters automation and AI based on LSEG and company data. It was checked and edited by a Reuters journalist prior to publication.)

免責聲明:投資有風險,本文並非投資建議,以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請,作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考,不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證,投資者應自行研究並在投資前尋求專業建議。

熱議股票

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10